Biologics are specialized drugs that target specific parts of the immune system. When used to treat psoriasis, they block the actions of certain cells and proteins that are part of the process ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

Biologics target specific parts of the immune system directly impacted by psoriasis, and they’re a big deal in both the medical community and to many with psoriasis. “Biologics are probably ...

SAN DIEGO — Disease-modifying antirheumatic drugs (DMARDs) and biologics were linked to as much as a 74.5% reduction in the risk for alopecia areata (AA) in patients with psoriasis, a new ...

As a group, these new medications are commonly referred to as "biologics" and represent the most current attempt to target specific steps in the immune mechanisms underlying psoriasis. It is the ...

Investigators determine risks for adverse events and infections in patients with moderate to severe psoriasis treated with biologics with vs without methotrexate. The risk for adverse events among ...

Because biologics are used to treat both conditions, researchers hypothesized they may be helpful to prevent psoriatic arthritis (PsA). The use of biologics may reduce the development of psoriatic ...

Many people with psoriasis change medications at some point during treatment. So, whether your old medication isn’t working as well or you’re having too many side effects, here’s how to make ...